Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Avoid These 3 Sell-Rated Stocks at All Costs

Published 05/18/2021, 12:10 PM
Updated 05/18/2021, 01:30 PM
© Reuters.  Avoid These 3 Sell-Rated Stocks at All Costs

The market's recently volatility has made some investors step back and think about their holdings. While this bout of volatility may be temporary, it's always good to stick to stocks that have a higher potential for outperformance and avoid stocks that have a higher potential for underperformance. That's why you should avoid recently downgraded stocks such as Cardlytics (NASDAQ:CDLX), CorMedix (CRMD), and fuboTV (FUBO).The POWR Ratings are updated on a daily basis where some stocks are upgraded, and others are downgraded. We tell investors to focus on stocks with an overall grade of A or B as they offer the highest potential for gains. But just as important, investors should avoid stocks with an overall grade of D or F.

So, if you own a stock that was recently downgraded to a D or F, it may be time to sell. Even if you don't hold a stock with a D or F grade, you still need to make sure to avoid those that were recently downgraded. With the market showing higher volatility over the past week, it's even more important now.

Below, I shine the spotlight on three recent POWR Ratings downgrades you should avoid: Cardlytics (CDLX), CorMedix (CRMD), and fuboTV (FUBO).

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.